- Home
- CADL vs PAII Comparison
CADL vs PAII Comparison
Compare CADL & PAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$6.35
Company Overview
Basic Information| Metric | CADL | PAII |
|---|---|---|
| Founded | 1999 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 275.4M |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CADL | PAII |
|---|---|---|
| Price | $6.35 | $10.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $19.43 | N/A |
| AVG Volume (30 Days) | ★ 936.0K | 40.3K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.25 | $9.92 |
| 52 Week High | $13.68 | $10.12 |
Technical Indicators
Market Signals| Indicator | CADL | PAII |
|---|---|---|
| Relative Strength Index (RSI) | 72.12 | N/A |
| Support Level | $5.39 | N/A |
| Resistance Level | $6.83 | N/A |
| Average True Range (ATR) | 0.36 | 0.00 |
| MACD | 0.22 | 0.00 |
| Stochastic Oscillator | 80.81 | 0.00 |
Price Performance
Historical Comparison CADL
PAII
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About PAII Pyrophyte Acquisition Corp. II Class A Ordinary Shares
Pyrophyte Acquisition Corp II is a special purpose acquisition company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.